This is a solicitation for Fingolimod 0. 5 mg Capsules, 30 count bottle. Offers must be submitted electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS). The submission deadline is July 9, 2026, at 3:00 PM EST. This is a requirements contract with a one-year base period and four option years. The contract awardee will receive payments from Prime Vendors, not directly from the government. The contractor must enter into business-to-business agreements with DLA and VA Prime Vendors. Delivery to Prime Vendor distribution centers is required within 15 calendar days after receipt of order. Product information must be registered with RxNorm, First Data Bank, and Medi-Span prior to contract performance. Bar code labeling at the unit-of-use package level is required. A 0. 5% cost recovery fee is embedded in the contract prices and must be reported quarterly.
The closing date for offers is July 09, 2026, at 3:00 PM EST. Delivery to Prime Vendor distribution centers is required within 15 calendar days after receipt of order.
Under this contract, the contractor will be receiving payments from the Prime Vendors instead of directly from the government. Invoices will be submitted in accordance with the business-to-business agreements reached with the Prime Vendors.
Offerors must have on file, if required by FDA, an FDA approved new drug application (NDA), an approved abbreviated NDA (ANDA), or a biologic license approval by the solicitation's closing date.
If a national contract item is backordered and determined to be awardee-caused, the awardee will issue credit or reimburse the government for the difference between the purchase price and the contract price within 30 calendar days after receipt of notification.
A contractor may be suspended and/or debarred for knowing failure by a principal to timely disclose to the government credible evidence of a violation of federal criminal law involving fraud, conflict of interest, bribery, or gratuity violations, or a violation of the false claims act.